87174009: Guaifenesin (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Respiratory system agent (substance)\Cough AND/OR decongestant agent (substance)\Expectorant agent (substance)\Guaifenesin

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Substance with ether structure\Methyl ether (substance)\Guaifenesin

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Guaifenesin	Is a	Medicinal product acting as expectorant agent (product)	false	Inferred relationship	Some
Guaifenesin	Is a	Expectorant agent (substance)	true	Inferred relationship	Some
Guaifenesin	Is a	Guaifenesin and derivatives	false	Inferred relationship	Some
Guaifenesin	Is a	Methyl ether (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Guaifenesin 200 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Some	1
Guaifenesin 200 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Guaifenesin	Inferred relationship	Some	1
Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Some	1
Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Guaifenesin	Inferred relationship	Some	1
Diprophylline 200 mg and guaifenesin 100 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Some	1
Diprophylline 200 mg and guaifenesin 100 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Guaifenesin	Inferred relationship	Some	1
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Guaifenesin	Inferred relationship	Some	1
Ephedrine sulfate 25 mg and guaifenesin 400 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Some	2
Ephedrine sulfate 25 mg and guaifenesin 400 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Guaifenesin	Inferred relationship	Some	2
Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Guaifenesin	Inferred relationship	Some	2
Diprophylline 200 mg and guaifenesin 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Some	2
Diprophylline 200 mg and guaifenesin 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Guaifenesin	Inferred relationship	Some	2
Ephedrine hydrochloride 12.5 mg and guaifenesin 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Some	2
Ephedrine hydrochloride 12.5 mg and guaifenesin 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Guaifenesin	Inferred relationship	Some	2
Diprophylline 100 mg and guaifenesin 100 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Guaifenesin	Inferred relationship	Some	1
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Guaifenesin	Inferred relationship	Some	1
Guaifenesin 1200mg /pseudoephedrine 120mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Some
Guaifenesin 1200mg /dextromethorphan 60mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Some
Guaifenesin 600mg /dextromethorphan 30mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Some
Guaifenesin 600mg /pseudoephedrine 60mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Some
Guaifenesin 1200mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Some
Guaifenesin 600mg prolonged-release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Some
Guaifenesin 300mg prolonged-release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Some
Product containing precisely guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Guaifenesin	Inferred relationship	Some	1
Product containing precisely guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	1
Product containing guaifenesin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	1
Diprophylline 100 mg and guaifenesin 100 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Guaifenesin	Inferred relationship	Some	1
Diprophylline 200 mg and guaifenesin 200 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Guaifenesin	Inferred relationship	Some	1
Guaifenesin 1 g oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	1
Guaifenesin 800 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	1
Guaifenesin 575 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	1
Guaifenesin 600 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	1
Ephedrine sulfate 25 mg and guaifenesin 400 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	2
Guaifenesin 100 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	1
Guaifenesin 200 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	1
Guaifenesin 675 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	1
Product containing precisely guaifenesin 300 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	1
Product containing precisely guaifenesin 1.2 gram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	1
Guaifenesin 200 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	1
Ephedrine- and guaifenesin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	2
Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	2
Product containing diprophylline and guaifenesin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	2
Ephedrine hydrochloride 12.5 mg and guaifenesin 200 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	2
Diprophylline 200 mg and guaifenesin 100 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	2
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Guaifenesin	Inferred relationship	Some	1
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Guaifenesin	Inferred relationship	Some	1
Guaifenesin- and theophylline-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	2
Product containing brompheniramine and guaifenesin and hydrocodone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	3
Product containing brompheniramine and guaifenesin and hydrocodone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	3
Product containing chlorphenamine and guaifenesin and hydrocodone and pseudoephedrine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	4
Product containing only guaifenesin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	1
Product containing only guaifenesin and pseudoephedrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	2
Product containing only guaifenesin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	1
Product containing guaifenesin and pseudoephedrine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	2
Product containing only guaifenesin and pseudoephedrine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	2
Product containing only brompheniramine and guaifenesin and hydrocodone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	3
Product containing only cetylpyridinium and guaifenesin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	2
Chlorphenamine and guaifenesin and hydrocodone and pseudoephedrine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	4
Product containing only dextromethorphan and guaifenesin and pseudoephedrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	3
Dextromethorphan and guaifenesin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	2
Product containing only dextromethorphan and guaifenesin and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	3
Product containing only codeine and guaifenesin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	2
Codeine and guaifenesin and pseudoephedrine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	3
Product containing only dexbrompheniramine and guaifenesin and paracetamol and pseudoephedrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	4
Product containing only diprophylline and guaifenesin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	2
Ephedrine and guaifenesin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	2
Product containing only guaifenesin and theophylline (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	2
Product containing only guaifenesin and hydrocodone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	2
Product containing only guaifenesin and phenylephrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	2
Product containing only guaifenesin and phenylephrine and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	3
Guaifenesin and phenylpropanolamine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	2
Brompheniramine and guaifenesin and hydrocodone only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	3
Ephedrine and guaifenesin only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	2
Product containing only chlorphenamine and guaifenesin and hydrocodone and pseudoephedrine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	4
Product containing only guaifenesin and theophylline in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	2
Diprophylline and guaifenesin only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	2
Product containing precisely guaifenesin 50 milligram/1 milliliter conventional release oral solution (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Guaifenesin	Inferred relationship	Some	1
Product containing precisely guaifenesin 50 milligram/1 milliliter conventional release oral solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	1
Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	2
Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Guaifenesin	Inferred relationship	Some	2
Product containing precisely guaifenesin 20 milligram/1 milliliter conventional release oral solution (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Guaifenesin	Inferred relationship	Some	1
Product containing precisely guaifenesin 20 milligram/1 milliliter conventional release oral solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	1
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Guaifenesin	Inferred relationship	Some	2
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	2
Product containing only dextromethorphan and guaifenesin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	2
Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Guaifenesin	Inferred relationship	Some	2
Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	2
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Guaifenesin	Inferred relationship	Some	2
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	2
Dextromethorphan- and guaifenesin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Some	2
Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	3
Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Guaifenesin	Inferred relationship	Some	3
Product containing precisely diprophylline 6.67 milligram/1 milliliter and guaifenesin 6.67 milligram/1 milliliter conventional release oral solution (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Guaifenesin	Inferred relationship	Some	2
Product containing precisely diprophylline 6.67 milligram/1 milliliter and guaifenesin 6.67 milligram/1 milliliter conventional release oral solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	2
Diprophylline 100 mg and guaifenesin 100 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	2
Diprophylline 200 mg and guaifenesin 200 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	2
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	2
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	2
Product containing precisely guaifenesin 10 milligram/1 milliliter conventional release oral solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	1
Product containing precisely guaifenesin 10 milligram/1 milliliter conventional release oral solution (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Guaifenesin	Inferred relationship	Some	1
Ambroxol hydrochloride 3 mg/mL and guaifenesin 10 mg/mL and terbutaline sulfate 250 microgram/mL oral solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Guaifenesin	Inferred relationship	Some	3

Start Page 2 of 3 End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
144553013	Guaifenesin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
144555018	Glyceryl guaiacolate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
144556017	Guaianesin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
829592015	Guaifenesin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2989358018	Guaiphenesin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3700273012	Alpha-glyceryl guaiacol ether	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
50211000195117	guaifenesina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
861291000172119	guaïfénésine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
64361000195114	Guaifenesin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module